Version 2.78

Part Descriptions

LP64724-5   Darunavir
Darunavir (Prezista) is a drug used to treat HIV infection. It is in the protease inhibitor class. Prezista is an OARAC recommended treatment option for treatment-naïve and treatment-experienced adults and adolescents. Developed by pharmaceutical company Tibotec, darunavir is named after Arun K. Ghosh, the chemist who discovered the molecule at the University of Illinois in Chicago. It was approved by the Food and Drug Administration (FDA) on June 23, 2006. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Darunavir

LP64724-5   Darunavir
Darunavir (brand name Prezista, formerly known as TMC114) is a drug used to treat HIV infection. It is in the protease inhibitor class. Prezista is an OARAC recommended treatment option for treatment-naïve and treatment-experienced adults and adolescents. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Wikipedia

Fully-Specified Name

Component
Darunavir
Property
Susc
Time
Pt
System
Isolate
Scale
OrdQn
Method
Phenotyping

Additional Names

Short Name
Darunavir Islt Phenotyp
Display Name
Darunavir Phenotype method [Susc]
Consumer Name Alpha Get Info
Susceptibility to Darunavir

Basic Attributes

Class
ABXBACT
Type
Laboratory
First Released
Version 2.22
Last Updated
Version 2.22
Order vs. Observation
Both

Member of these Panels

LOINC Long Common Name
49665-3 HIV susceptibility panel by Phenotype method

Member of these Groups Get Info

LOINC Group Group Name
LG41328-2 DarunavirSusc|Isolate

Language Variants Get Info

Tag Language Translation
es-ES Spanish (Spain) Darunavir:Susceptibilidad:Punto temporal:Aislado:Ordinal Cuantitativo:Susceptibilidad al fenotipo viral
es-MX Spanish (Mexico) Darunavir:Susceptibilidad (microorganismos):Punto temporal:Aislado:Ordinal Cuantitativo:Susceptibilidad del fenotipo viral
et-EE Estonian (Estonia) Darunaviir:Susc:Pt:Is:OrdQn:Fenotüpiseerimine
Synonyms: Isolaat Juhuslik Tundlikkus
fr-CA French (Canada) Darunavir:Susceptibilité:Temps ponctuel:Isolat:Quantitatif ou ordinal:Phénotypage
fr-FR French (France) Darunavir:Sensibilité:Ponctuel:Isolat:Alphanumérique:Phénotypage
fr-BE French (Belgium) Darunavir:Susceptibilité:Temps ponctuel:Isolat:Quantitatif ou ordinal:Phénotypage
it-IT Italian (Italy) Darunavir:Susc:Pt:Isolato:OrdQn:Fenotipizzazione
Synonyms: Punto nel tempo (episodio) Sensibilità (microrganismi) Suscettibilità agli antibiotici Suscettibilità fenotipo virale
nl-NL Dutch (Netherlands) darunavir:gevoeligheid:moment:isolaat:ordinaal-kwantitatief:fenotypering
pt-BR Portuguese (Brazil) Darunavir:Susc:Pt:Isolado:OrdQn:Fenotipagem
Synonyms: Prezista; TMC114; DRV; Susceptibility; Susceptibilty; Sus; Suscept; Susceptibilities; Point in time; Random; Islt; Isol; Phenotyp; Phenotype; Phenotypic; Pheno; ANTIBIOTIC SUSCEPTIBILITIES; Virtual Phenotype
tr-TR Turkish (Turkey) Darunavir:Duyr:Zmlı:İzolat:SrlKant:Fenotipleme
zh-CN Chinese (China) 地瑞那韦:抗生素敏感性:时间点:分离株:定量型或序数型:表现型分型
Synonyms: Darunavir;DRV;Prezista;TMC114;达如那韦 分离物;分离菌;分离菌株;隔离种群 实质表型 实质表现型 实际表型 实际表现型 抗生素敏感性(微生物);敏感性;某种抗微生物制剂对于某个分离株的影响;药物敏感性;药物敏感性(微生物) 抗生素敏感性表型分型 抗生素敏感性表型分析 抗生素敏感性表型鉴定 抗生素敏感性表现型分析 抗生素敏感性表现型鉴定 抗生素敏感性试验;药敏;药敏类;药敏试验;药敏试验类 时刻;随机;随意;瞬间 病毒表现型敏感性试验;表型分型;表型分析;表型定型;表现型分析;表现型定型 虚拟表型 虚拟表现型 虚拟表现型（Virtual Phenotype） 表型分型 表型分析 表型鉴定 表现型分析

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=49666-1